Patent · US Active

Pump homeostasis indicator (PHI)

US10856804B2 · kind B2 · utility

0Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2018
Grant dateDec 8, 2020
Priority date
Expiry dateFeb 15, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/3365
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method determining adverse events from operation of an implantable blood pump including calculating a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump. An alert is generated when the calculated MACD diverges from a predetermined MACD threshold and a predetermined MACD zero-crossing time threshold.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.